Insiders · Profile

Meredith Ian T

EVP Global Chief Med Officer at Boston Scientific. Filing since 28 Dec 2021. CIK 0001693920

Company
Date
Role
Action
Shares
Amount
Of holding
28 Mar 2022
EVP Global Chief Med Officer
Sold, plan not stated
6,588
$287.76K
19.0%
28 Dec 2021
EVP Global Chief Med Officer
Sold, plan not stated
7,018
$303.25K
21.1%
2 decisions on file.